Threshold Settles Shareholder Action For $10M
By Christine Caulfield · November 10, 2009, 12:57 PM EST
Threshold Pharmaceuticals Inc. has agreed to pay $10 million to settle a securities fraud action that alleged the biotechnology company and its top executive misled investors ahead of its initial public...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login